Author

Sinead Smith

PROTEIN-LIGAND DOCKING AND IN VITRO SCREENING AS A TOOL TO IDENTIFY LEAD HIT DRUGS TARGETING THE KEY SURVIVAL PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) ENZYME OF HELICOBACTER PYLORI
PROTEIN-LIGAND DOCKING AND IN VITRO SCREENING AS A TOOL TO IDENTIFY LEAD HIT DRUGS TARGETING THE KEY SURVIVAL PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) ENZYME OF HELICOBACTER PYLORI

Sinead Smith  et al.

THE NOTCH PATHWAY TRANSCRIPTION FACTOR HES1 REGULATES EXPRESSION OF THE PRO-INFLAMMATORY CYTOKINE IL-8 DURING H. PYLORI INFECTION
THE NOTCH PATHWAY TRANSCRIPTION FACTOR HES1 REGULATES EXPRESSION OF THE PRO-INFLAMMATORY CYTOKINE IL-8 DURING H. PYLORI INFECTION

Sinead Smith  et al.

AN EVOLVING RESISTANT PANDEMIC. RISING COMMUNITY H. PYLORI TREATMENT FAILURE TO CLARITHROMYCIN-BASED TRIPLE THERAPY: AN OBSERVATIONAL STUDY
AN EVOLVING RESISTANT PANDEMIC. RISING COMMUNITY H. PYLORI TREATMENT FAILURE TO CLARITHROMYCIN-BASED TRIPLE THERAPY: AN OBSERVATIONAL STUDY

Sinead Smith  et al.

PCR IMPROVES DETECTION OF HELICOBACTER PYLORI IN UNSELECTED ADULT PATIENTS UNDERGOING ROUTINE GASTROSCOPY
PCR IMPROVES DETECTION OF HELICOBACTER PYLORI IN UNSELECTED ADULT PATIENTS UNDERGOING ROUTINE GASTROSCOPY

Sinead Smith  et al.

HELICOBACTER PYLORI INFECTION INHIBITS EXPRESSION AND FUNCTION OF THE POLYCOMB REPRESSIVE COMPLEX 2
HELICOBACTER PYLORI INFECTION INHIBITS EXPRESSION AND FUNCTION OF THE POLYCOMB REPRESSIVE COMPLEX 2

Sinead Smith  et al.

EVALUATION OF MOLECULAR-BASED CLARITHROMYCIN RESISTANCE TESTING IN HELICOBACTER PYLORI COMPARED TO CULTURE-BASED TESTING IN THE IRISH HEALTHCARE SETTING
EVALUATION OF MOLECULAR-BASED CLARITHROMYCIN RESISTANCE TESTING IN HELICOBACTER PYLORI COMPARED TO CULTURE-BASED TESTING IN THE IRISH HEALTHCARE SETTING

Sinead Smith  et al.

CLARITHROMYCIN RESISTANCE IS MORE COMMON AMONG LESS VIRULENT HELICOBACTER PYLORI STRAINS - DATA FROM AN IRISH CENTRE
CLARITHROMYCIN RESISTANCE IS MORE COMMON AMONG LESS VIRULENT HELICOBACTER PYLORI STRAINS - DATA FROM AN IRISH CENTRE

Sinead Smith  et al.

IRISH HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE SURVEILLANCE TO GUIDE CLINICAL PRACTICE
IRISH HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE SURVEILLANCE TO GUIDE CLINICAL PRACTICE

Sinead Smith  et al.

ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Sinead Smith  et al.

EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Sinead Smith  et al.

EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

Sinead Smith  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Sinead Smith  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Sinead Smith  et al.

TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Sinead Smith  et al.

FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

Sinead Smith  et al.

CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Sinead Smith  et al.

THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Sinead Smith  et al.

TIME TRENDS AND EFFECTIVENESS OF BISMUTH TREATMENT FOR HELICOBACTER PYLORI INFECTION: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG) DURING 2013-2021
TIME TRENDS AND EFFECTIVENESS OF BISMUTH TREATMENT FOR HELICOBACTER PYLORI INFECTION: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG) DURING 2013-2021

Sinead Smith  et al.

ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Sinead Smith  et al.

Item 1 - 19 / 19
1